TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details

Profile for Mary Klein, PharmD

Mary Klein

Mary Klein, PharmD

  • Clinical Pharmacist
  • Assistant Professor of Pharmacy Practice
Office Phone: 325-696-0445
Mail Address: 1718 Pine St
Abilene TX 79601-3044


Dr. Klein is involved primarily with laboratory teaching and maintains a practice site at the TTUHSC Abilene Community Health Center. Dr. Klein teaches in Clinical Immunizations and Administration, Patient Assessment, and Pharmaceutical Care Lab, in addition to precepting the P3 and P4 Ambulatory Care rotations. Dr. Klein received her Bachelor of Science degree in Biology from Texas Tech University in 2003 and Doctor of Pharmacy from the TTUHSC School of Pharmacy in 2007. She then completed a community and ambulatory care pharmacy practice (PGY1) residency at the University of Texas at Austin/Scott and White Memorial Hospital, Health Plan, and Clinics in Temple and Georgetown, Texas. Her practice interests include family medicine, endocrinology, primary care, and interprofessional education. Research interesting including diabetes clinical outcomes research and educational design.

Selected Publications:

  • McCutcheon L, Whitcomb K, Cox CD, Klein MS, Hansel B, Youngblood T, Raehl CL. Simulation-interprofessional education (SIM-IPE) model to train preceptors. Simulation in Healthcare 2015;10(6):438.
  • Ochoa PS, Terrell B, Vega JA, Lu C, Klein MS, . Identification of Previously Undiagnosed Diabetes and Prediabetes in the Inpatient Setting Using Risk Factor and Hemoglobin A1C Screening. Annals of Pharmacotherapy 2014.
  • Klein MS. Achieving Cholesterol Goals with Low-Cost 3-hydroxy-3- methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors in an Indigent Diabetic Population. JHPR 2014.
  • Horton NA, Payne KD, Frost J, Wise S, Klein MS, Epps JM, . A standardized patient counseling rubric for a pharmaceutical care and communications course. Am J Pharm Educ 2013;77:152.
  • Minze MG, Klein MS, Terrell B. Saxagliptin-metformin in fixed combination for the treatment of type 2 diabetes in adults. Clin Med Insights Endocrinol Diabetes. 2013;6:15-24.